The Food and Drug Administration approved a new use for Sunovion Pharmaceuticals’ Latuda to treat schizophrenia in kids aged 13 to 17 years. The drug was first approved in 2010 as a treatment for ...
The FINANCIAL — Sumitomo Dainippon Pharma Co., Ltd. and Takeda Pharmaceutical Company Limited on May 7 jointly announced that their license agreement entered into in March 2011 (“Agreement”) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results